Introduction: The aim of this study was to compare the outcomes of on-clamp and off-clamp robotic partial nephrectomy (RPN). Materials and Methods: The charts of all patients who underwent an RPN at 8 institutions between 2010 and 2014 were retrospectively reviewed. The patients who underwent an off-clamp RPN were matched to on-clamp RPN in a 1-4 fashion according to the following variables: RENAL score, tumor size and surgeon's experience. Pre-, intra-, and postoperative data were compared between both groups. Results: Among 525 RPN, 26 were performed off-clamp (5%). They were matched to 104 on-clamp RPN. The complications rate (15.5 vs. 7.7%, p = 0.53), major complications rate (4.9 vs. 3.9%; p = 0.82), and transfusions rate (0 vs. 4.9%; p = 0.58) did not differ significantly between the clamped and unclamped groups. Conversely, estimated blood loss was higher in the off-clamp group (266.4 vs. 284.6 mL, p = 0.048) and so was the rate of conversion to radical nephrectomy (0 vs. 7.7%, p = 0.04). Postoperative preservation of renal function was comparable in both groups. Conclusion: Off-clamp RPN is feasible for a small subgroup of renal tumors without increased risk of postoperative complications but at the cost of higher estimated blood loss and increased risk of conversion to radical nephrectomy.

Keywords:
Partial nephrectomy, Kidney neoplasms, Laparoscopy, Blood loss, Surgical technique
1.
Becker F, Siemer S, Hack M, Humke U, Ziegler M, Stöckle M: Excellent long-term cancer control with elective nephron-sparing surgery for selected renal cell carcinomas measuring more than 4 cm. Eur Urol 2006;49:1058-1063; discussion 1063-1064.
2.
Long CJ, Canter DJ, Kutikov A, Li T, Simhan J, Smaldone M, et al: Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes. BJU Int 2012;109:1450-1456.
3.
Huang WC, Elkin EB, Levey AS, Jang TL, Russo P: Partial nephrectomy versus radical nephrectomy in patients with small renal tumors - is there a difference in mortality and cardiovascular outcomes? J Urol 2009;181:55-61; discussion 61-62.
4.
Tan HJ, Norton EC, Ye Z, Hafez KS, Gore JL, Miller DC: Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer. JAMA 2012;307:1629-1635.
5.
Bensalah K, Albiges L, Bernhard JC, et al: [CCAFU French national guidelines 2016-2018 on renal cancer]. Prog Urol 2016;27(suppl 1):S27-S51.
6.
Gill IS, Kavoussi LR, Lane BR, Blute ML, Babineau D, Colombo JR Jr, et al: Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 2007;178:41-46.
7.
Ji C, Zhao X, Zhang S, Liu G, et al: Laparoscopic radiofrequency ablation versus partial nephrectomy for cT1a renal tumors: long-term outcome of 179 patients. Urol Int 2016;96:345-353.
8.
Campbell SC, Novick AC: Surgical technique and morbidity of elective partial nephrectomy. Semin Urol Oncol 1995;13:281-287.
9.
Rod X, Peyronnet B, Seisen T, Pradere B, Gomez FD, Verhoest G, et al: Impact of ischaemia time on renal function after partial nephrectomy: a systematic review. BJU Int 2016;118:692-705.
10.
Boyarsky L, Stein A, Konstantinovsky A, et al: Retrospective analysis of laparoscopic partial nephrectomies using the zero ischemia technique. Urol Int 2017, in press.
11.
Kutikov A, Uzzo RG: The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 2009;182:844-853.
12.
Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-213.
13.
Peyronnet B, Baumert H, Mathieu R, Masson-Lecomte A, Grassano Y, Roumiguié M, et al: Early unclamping technique during robot-assisted laparoscopic partial nephrectomy can minimise warm ischaemia without increasing morbidity. BJU Int 2014;114:741-747.
14.
Thompson RH, Lane BR, Lohse CM, et al: Every minute counts when the renal hilum is clamped during partial nephrectomy. Eur Urol 2010;58:340-345.
15.
Gill IS, Eisenberg MS, Aron M, Berger A, Ukimura O, Patil MB, et al: “Zero ischemia” partial nephrectomy: novel laparoscopic and robotic technique. Eur Urol 2011;59:128-134.
16.
Bahi R, Pignot G, Hammoudi Y, Bensalah K, Oger E, Laguna P, et al: [Ischemia is not an independent predictive factor of chronic renal failure after partial nephrectomy in a solitary kidney in patients without pre-operative renal insufficiency]. Prog Urol 2015;25:27-33.
17.
Trehan A: Comparison of off-clamp partial nephrectomy and on-clamp partial nephrectomy: a systematic review and meta-analysis. Urol Int 2014;93:125-134.
18.
Liu W, Li Y, Chen M, Gu L, Tong S, Lei Y, et al: Off-clamp versus complete hilar control partial nephrectomy for renal cell carcinoma: a systematic review and meta-analysis. J Endourol 2014;28:567-576.
19.
Satkunasivam R, Tsai S, Syan S, Bernhard JC, de Castro Abreu AL, Chopra S, et al: Robotic unclamped “minimal-margin” partial nephrectomy: ongoing refinement of the anatomic zero-ischemia concept. Eur Urol 2015;68:705-712.
20.
Khene ZE, Peyronnet B, Mathieu R, Fardoun T, Verhoest G, Bensalah K: Analysis of the impact of adherent perirenal fat on peri-operative outcomes of robotic partial nephrectomy. World J Urol 2015;33:1801-1806.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.